Ligand-based virtual screening under partial shape constraints

Ligand-based virtual screening has proven to be a viable technology during the search for new lead structures in drug discovery. Despite the rapidly increasing number of published methods, meaningful shape matching as well as ligand and target flexibility still remain open challenges. In this work, we analyze the influence of knowledge-based sterical constraints on the performance of the recently published ligand-based virtual screening method mRAISE. We introduce the concept of partial shape matching enabling a more differentiated view on chemical structure. The new method is integrated into the LBVS tool mRAISE providing multiple options for such constraints. The applied constraints can either be derived automatically from a protein–ligand complex structure or by manual selection of ligand atoms. In this way, the descriptor directly encodes the fit of a ligand into the binding site. Furthermore, the conservation of close contacts between the binding site surface and the query ligand can be enforced. We validated our new method on the DUD and DUD-E datasets. Although the statistical performance remains on the same level, detailed analysis reveal that for certain and especially very flexible targets a significant improvement can be achieved. This is further highlighted looking at the quality of calculated molecular alignments using the recently introduced mRAISE dataset. The new partial shape constraints improved the overall quality of molecular alignments especially for difficult targets with highly flexible or different sized molecules. The software tool mRAISE is freely available on Linux operating systems for evaluation purposes and academic use (see http://www.zbh.uni-hamburg.de/raise).

[1]  Kesheng Wu,et al.  FastBit: An Efficient Indexing Technology For Accelerating Data-Intensive Science , 2005 .

[2]  Matthias Rarey,et al.  Facing the Challenges of Structure-Based Target Prediction by Inverse Virtual Screening , 2014, J. Chem. Inf. Model..

[3]  M. Rarey,et al.  SIENA: Efficient Compilation of Selective Protein Binding Site Ensembles , 2016, J. Chem. Inf. Model..

[4]  Jeffrey Skolnick,et al.  LIGSIFT: an open-source tool for ligand structural alignment and virtual screening , 2015, Bioinform..

[5]  A. S. Nascimento,et al.  MolShaCS: a free and open source tool for ligand similarity identification based on Gaussian descriptors. , 2013, European journal of medicinal chemistry.

[6]  J. Irwin,et al.  Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.

[7]  Mark S. Johnson,et al.  ShaEP: Molecular Overlay Based on Shape and Electrostatic Potential , 2009, J. Chem. Inf. Model..

[8]  A Lavecchia,et al.  Virtual screening strategies in drug discovery: a critical review. , 2013, Current medicinal chemistry.

[9]  William L. Jorgensen,et al.  Search for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Using Chemical Similarity, Molecular Docking, and MM-GB/SA Scoring , 2007, J. Chem. Inf. Model..

[10]  Matthias Rarey,et al.  An integrated approach to knowledge-driven structure-based virtual screening , 2014, Journal of Computer-Aided Molecular Design.

[11]  Gert Thijs,et al.  Pharao: pharmacophore alignment and optimization. , 2008, Journal of molecular graphics & modelling.

[12]  J. A. Grant,et al.  A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape , 1996, J. Comput. Chem..

[13]  Matthias Rarey,et al.  mRAISE: an alternative algorithmic approach to ligand-based virtual screening , 2016, Journal of Computer-Aided Molecular Design.

[14]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[15]  Matthias Rarey,et al.  Evidence of Water Molecules - A Statistical Evaluation of Water Molecules Based on Electron Density , 2015, J. Chem. Inf. Model..

[16]  Pierre Baldi,et al.  Structure-based inhibitor design of AccD5, an essential acyl-CoA carboxylase carboxyltransferase domain of Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[18]  Stefano Costanzi,et al.  Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening. , 2008, Journal of medicinal chemistry.

[19]  Lin Ting‐Wan,et al.  Mycobacterium tuberculosisの必須アシル‐CoAカルボキシラーゼカルボキシルトランスフェラーゼドメインAccD5の構造依存阻害剤デザイン , 2006 .

[20]  Matthias Rarey,et al.  Fast Protein Binding Site Comparison via an Index-Based Screening Technology , 2013, J. Chem. Inf. Model..

[21]  K.-C. Chou,et al.  Anti-SARS drug screening by molecular docking , 2006, Amino Acids.

[22]  Matthias Rarey,et al.  MONA 2: A Light Cheminformatics Platform for Interactive Compound Library Processing , 2015, J. Chem. Inf. Model..

[23]  J. Mestres,et al.  Similarity versus docking in 3D virtual screening , 2000 .

[24]  David Vidal,et al.  A Novel Search Engine for Virtual Screening of Very Large Databases , 2006, J. Chem. Inf. Model..